Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Series C raises $10mm for Regentis Biomaterials

Executive Summary

Regentis Biomaterials Ltd. (hydrogels for tissue regeneration) has raised $10mm in a Series C financing to first-time backers Royal DSM’s investment arm and Crossroad Fund, and returning shareholders Medica Venture Partners, SCPVitalife, and the Technion Investment Opportunities Fund.
Deal Industry
  • Biotechnology
  • Medical Devices
    • Biomaterials
    • Implantable Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies